Over the recent years, LNPs have paved new possibilities in the world of nanomedicine. From early stage research to clinical ...

Particle characteristics can affect pharmaceutical formulations and products in a number of ways, and a variety of techniques are available that enable particle monitoring and characterisation.

The global market for lipid nanoparticles (LNPs) hit $786 million in 2024 and is projected to grow 14% a year to 2030, driven by their increasing popularity as drug delivery vehicles.[1] The success ...

How effective powder characterization can lead to better powder understanding and control. Understanding and controlling powder behaviour can help to formulate clinically effective products, design ...